Impex Ferro Tech (IMPEXFERRO)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding of 69.10% shows significant insider skin in the game.
• Piotroski F-Score of 5/9 indicates some financial-health indicators are positive despite distress.
• Small market cap of ₹15 Cr means a genuine operational turnaround could have a large stock impact.

Concerns

• Latest quarter sales are ₹0 Cr with a net loss of ₹-2 Cr, meaning no active revenue generation.
• Book value is negative at ₹-36.91; liabilities exceed assets and equity is wiped out.
• ROCE is 0.00% and P/E is 0.00, making traditional valuation and return metrics meaningless.
• Reported free cash flow of ₹1.65 lakh Cr is wildly inconsistent with a ₹15 Cr market cap, raising data credibility concerns.

AI Analysis

At first glance, a ₹1.68 share price and ₹15 Cr market cap look like a small speculative stock. But I don't start with price; I start with the business. Impex Ferro Tech operates in ferro and silica manganese—a cyclical, commodity, price-taker industry. There is no moat here. The latest quarter shows sales of ₹0 Cr and a net loss of ₹-2 Cr. Zero revenue is not a temporary hiccup; it means the engine is not running. Book value is minus ₹36.91, so liabilities exceed assets. That destroys any asset-based margin of safety. The reported ROE of 9.06% is meaningless when equity is negative; it is a mathematical artifact of losses. ROCE is 0.00%, confirming no productive return on capital. With P/E of 0.00 and Debt/Equity N/A, traditional valuation metrics fail. The so-called free cash flow of ₹1.65 lakh Cr is absurd next to a ₹15 Cr market cap; I cannot rely on that number. On the positive side, promoter holding is 69.10%, so owners have skin in the game, and the Piotroski F-Score of 5/9 suggests a few financial health indicators are not all negative. Profit growth of 1.09% is tiny, but at least not a steep decline. Still, a zero-sales, loss-making, negative-net-worth company is not a Graham bargain. It is a speculative turnaround, not an investment. I would need evidence of resumed sales, positive operating cash flow, and a repaired balance sheet before I could even consider it. As Ben Graham said, the investor's chief problem is likely to be himself. This stock tempts the gambler. I will pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer